Bank of America Securities analyst Tazeen Ahmad maintained a Buy rating on Incyte (INCY – Research Report) today and set a price target of $87.00. The company’s shares closed yesterday at $57.73.

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Exact Sciences (NASDAQ:EXAS) and its peers. Over the next few ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Today we are looking at Incyte (NASDAQ:INCY) and the best and worst performers in the immuno-oncology industry. MADISON, Wis., April 01, 2025--Exact Sciences Corp. (Nasdaq: EXAS), a leading ...

Malayalam actor Shine Tom Chacko, who escaped during a police raid in connection with an alleged drug use complaint against him, was caught in another controversy when his colleague Vincy Aloshious ...

Malayalam actor Vincy Aloshious revealed that her co-star, allegedly under the influence of drugs, insisted on fixing her dress. However, she did not name the person. Listen to Story Vincy Aloshious ...